THE EFFECT OF AVACOPAN, A COMPLEMENT C5A RECEPTOR INHIBITOR, ON KIDNEY FUNCTION IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS WITH RENAL DISEASE

被引：0
|
作者：
Jayne, David [1 ]
Merkel, Peter [2 ]
Bekker, Pirow [3 ]
McMahon, Jeffrey [3 ]
Schall, Thomas J. [3 ]
机构：
[1] Univ Cambridge, Dept Med, Cambridge, England
[2] Hosp Univ Penn, Div Rheumatol, 3400 Spruce St, Philadelphia, PA 19104 USA
[3] ChemoCentryx Inc, Mountain View, CA USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
FC032
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Long-term outcome of kidney function in patients with ANCA-associated vasculitis
    Sachez-Alamo, Beatriz
    Moi, Laura
    Bajema, Ingeborg
    Berden, Annelies
    Flossmann, Oliver
    Hruskova, Zdenka
    Jayne, David
    Wester-Trejo, Maria
    Wallquist, Carin
    Westman, Kerstin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (09) : 1483 - 1493
  • [42] Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial
    Geetha, Duvuru
    Dua, Anisha
    Yue, Huibin
    Springer, Jason
    Salvarani, Carlo
    Jayne, David
    Merkel, Peter
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (02) : 223 - 232
  • [43] EFFICACY AND SAFETY OF AVACOPAN IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS RECEIVING RITUXIMAB IN THE ADVOCATE TRIAL
    Geetha, D.
    Dua, A.
    Yue, H.
    Salvarani, C.
    Jayne, D.
    Merkel, P. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 338 - 339
  • [44] ENT involvement is related to better renal function in patients with ANCA-associated vasculitis
    Rahmattulla, C.
    Van Wijngaarden, R. A. F. De Lind
    Berden, A. E.
    Hauer, H. A.
    Flomann, O.
    Jayne, D. R. W.
    Gaskin, G.
    Rasmussen, N.
    Noel, L. H.
    Ferrario, F.
    Waldherr, R.
    Pusey, C. D.
    Hagen, E. C.
    Bruijn, J. A.
    Bajema, I. M.
    PRESSE MEDICALE, 2013, 42 (04): : 662 - 663
  • [45] ENT involvement is related to better renal function in patients with ANCA-associated vasculitis
    van Wijngaarden, Robert de Lind
    Hauer, Herbert
    Flossmann, Oliver
    Jayne, David
    Gaskin, Gill
    Rasmussen, Niels
    Noel, Laure-Helene
    Ferrario, Franco
    Waldherr, Ruediger
    Pusey, Charles
    Hagen, E. Christiaan
    Bruijn, Jan
    Bajema, Ingeborg
    APMIS, 2009, 117 : 138 - 138
  • [46] Erratum to: Plasma complement factor H is associated with disease activity of patients with ANCA-associated vasculitis
    Su-Fang Chen
    Feng-Mei Wang
    Zhi-Ying Li
    Feng Yu
    Ming-Hui Zhao
    Min Chen
    Arthritis Research & Therapy, 19
  • [47] Interest of a Kidney Biopsy to Rule out ANCA-Associated Renal Vasculitis in Glomerulonephritis Patients with a Positive ANCA
    Garo, Florian
    Aglae, Cedric
    Perrochia, Helene
    Ahmadpoor, Pedram
    Daniel, Laurent
    Moranne, Olivier
    CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2022, 12 (01): : 73 - 80
  • [48] ANCA-associated renal vasculitis at the end of the twentieth century - a disease of older patients
    Harper, L
    Savage, CO
    RHEUMATOLOGY, 2005, 44 (04) : 495 - 501
  • [49] COST-UTILITY ANALYSIS OF AVACOPAN FOR THE TREATMENT OF ANCA-ASSOCIATED VASCULITIS (AAV) PATIENTS IN THE UK
    Serna, Ramirez de Arellano A.
    Berdunov, V
    Baxter, G.
    VALUE IN HEALTH, 2022, 25 (12) : S130 - S130
  • [50] Avacopan for ANCA-Associated Vasculitis in Ireland: A Report on All Patients Who Received Avacopan in the Irish Health Care System
    Nic an Riogh, Eithne Muireann
    Cummiskey, Andy Gerard
    Stoneman, Sinead
    Clarkson, Michael
    Moran, Sarah Margaret
    Magee, Ciara N.
    McAnallen, Susan Marie
    Little, Mark Alan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
12345